Literature DB >> 33291392

DDB2 Genetic Risk Factor for Ocular Squamous Cell Carcinoma Identified in Three Additional Horse Breeds.

Margo Crausaz1, Thomas Launois2, Kathryn Smith-Fleming3, Annette M McCoy3, Kelly E Knickelbein4, Rebecca R Bellone1,5.   

Abstract

Squamous cell carcinoma (SCC) is the most common cancer affecting the equine eye. A missense variant within the gene damage-specific DNA binding protein 2 (DDB2 c.1013C>T, p.Thr338Met) was previously identified as a causal recessive genetic risk factor for the development of ocular SCC within Haflingers, Belgian Draft horses, and Rocky Mountain Horses, but not in the Appaloosa or Arabian breeds. This study aimed to evaluate three cases of ocular SCC in additional breeds and determine if DNA testing for the DDB2 variant in warmblood horses and Connemara ponies is warranted. Histopathology confirmed ocular SCC in all three cases and DNA testing confirmed each horse was homozygous for the DDB2 risk factor. The DDB2 risk allele frequency was estimated to be 0.0043 for Holsteiners (N = 115), 0.014 for Belgian Warmbloods (N = 71), and 0.22 for Connemara Ponies (N = 86). Taken together these data support using DNA testing for DDB2 in Connemara Ponies to assist in mate selection and clinical management. Given the low observed allele frequencies in both the Holsteiner and Belgian Warmblood breeds and that the case under investigation was a warmblood cross-bred, evaluating additional SCC affected warmbloods is warranted to fully determine the importance of DDB2 genotyping as a risk factor in warmblood breeds.

Entities:  

Keywords:  cancer; damage-specific DNA binding protein 2 (DDB2); genetics; horse; ocular

Year:  2020        PMID: 33291392      PMCID: PMC7762027          DOI: 10.3390/genes11121460

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  28 in total

1.  Limbal squamous cell carcinoma in Haflinger horses.

Authors:  Mary Lassaline; Taryn L Cranford; Claire A Latimer; Rebecca R Bellone
Journal:  Vet Ophthalmol       Date:  2014-10-14       Impact factor: 1.644

2.  Carbon dioxide laser photoablation adjunctive therapy following superficial lamellar keratectomy and bulbar conjunctivectomy for the treatment of corneolimbal squamous cell carcinoma in horses: a review of 24 cases.

Authors:  Tammy M Michau; Michael G Davidson; Brian C Gilger
Journal:  Vet Ophthalmol       Date:  2011-12-13       Impact factor: 1.644

3.  Prognostic factors and survival of horses with ocular/adnexal squamous cell carcinoma: 147 cases (1978-1988).

Authors:  S J Dugan; S M Roberts; C R Curtis; G A Severin
Journal:  J Am Vet Med Assoc       Date:  1991-01-15       Impact factor: 1.936

4.  Expression of cyclooxygenase-2 by equine ocular and adnexal squamous cell carcinomas.

Authors:  Kerry M Smith; Timothy J Scase; Jodi L Miller; David Donaldson; Jane Sansom
Journal:  Vet Ophthalmol       Date:  2008-09       Impact factor: 1.644

5.  Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma.

Authors:  Kirsten Bogedale; Vidhya Jagannathan; Vinzenz Gerber; Lucia Unger
Journal:  Vet Comp Oncol       Date:  2019-02-15       Impact factor: 2.613

6.  The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites.

Authors:  Maria G Kapetanaki; Jennifer Guerrero-Santoro; Dawn C Bisi; Ching L Hsieh; Vesna Rapić-Otrin; Arthur S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

7.  Dynamic in vivo interaction of DDB2 E3 ubiquitin ligase with UV-damaged DNA is independent of damage-recognition protein XPC.

Authors:  Martijn S Luijsterburg; Joachim Goedhart; Jill Moser; Hanneke Kool; Bart Geverts; Adriaan B Houtsmuller; Leon H F Mullenders; Wim Vermeulen; Roel van Driel
Journal:  J Cell Sci       Date:  2007-07-17       Impact factor: 5.285

8.  Genetic risk for squamous cell carcinoma of the nictitating membrane parallels that of the limbus in Haflinger horses.

Authors:  M Singer-Berk; K E Knickelbein; S Vig; J Liu; E Bentley; C Nunnery; C Reilly; A Dwyer; C Drögemüller; L Unger; V Gerber; M Lassaline; R R Bellone
Journal:  Anim Genet       Date:  2018-07-12       Impact factor: 3.169

9.  A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for ocular squamous cell carcinoma in Belgian horses.

Authors:  K E Knickelbein; M E Lassaline; M Singer-Berk; C M Reilly; A B Clode; T R Famula; T M Michau; R R Bellone
Journal:  Equine Vet J       Date:  2019-04-15       Impact factor: 2.888

10.  Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses.

Authors:  Moriel H Singer-Berk; Kelly E Knickelbein; Zachary T Lounsberry; Margo Crausaz; Savanna Vig; Nikhil Joshi; Monica Britton; Matthew L Settles; Christopher M Reilly; Ellison Bentley; Catherine Nunnery; Ann Dwyer; Mary E Lassaline; Rebecca R Bellone
Journal:  Int J Genomics       Date:  2019-09-15       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.